Strategies for Artificial Intelligence in Healthcare : Generative Ai, Predictive Analytics, and the Future of Digital Medicine
Lingua: inglese
Editore: Taylor & Francis Okt 2026, 2026
- Rilegato
- Nuovo

Da: AHA-BUCH GmbH, Einbeck, GermaniaAHA-BUCH GmbH
Venditore AbeBooks dal 14 agosto 2006
Condizione: Nuovo
EUR 279,31
Quantità: 2 disponibili
Aggiungi al carrelloDescrizione dell’articolo da parte del venditore
Neuware - Strategies for Artificial Intelligence in Healthcare sheds light on the ever-changing world of Artificial Intelligence (AI) within the healthcare industry.As AI technology rapidly advances, the healthcare industry is becoming its most significant and impactful beneficiary. From the authors' viewpoint, AI is revolutionizing healthcare with the promise of improving patient outcomes, lowering costs, and increasing access and efficiency. The use of AI in healthcare is not a new concept. In fact, it has been around for decades, but it is only in recent years that its potential has been fully realized. From the development of new surgical techniques to the use of telemedicine for remote patient care, technology has revolutionized the way healthcare is delivered. With the rise of big data and cloud computing, AI will be an essential toolkit for healthcare professionals, enabling them to harness the immense data power in ways that were previously unimaginable. With real-world case studies, practical applications, and purpose methods, Strategies for Artificial Intelligence in Healthcare is the ultimate guide to navigating the modern healthcare industry with AI. The second edition provides up-to-date material and refreshes and updates case studies.Whether you're an experienced healthcare professional wanting to stay up to date or simply curious about the latest technology, this book offers unique and valuable insights for the future of healthcare with Artificial Intelligence by its side.…
Codice articolo 9781041117964
- Titolo
- Strategies for Artificial Intelligence in Healthcare : Generative Ai, Predictive Analytics, and the Future of Digital Medicine
- Autore
- Frank Papay
- Editore
- Taylor & Francis Okt 2026
- Anno di pubblicazione
- 2026
- Condizione
- Neu
- Rilegatura
- Buch
- Lingua
- inglese
- ISBN 10
- 1041117965
- ISBN 13
- 9781041117964
- Edizione
- seconda edizione
- Peso dell'articolo
- 667 grammi
- Dimensioni
- 254x178x16 mm
Strategies for Artificial Intelligence in Healthcare sheds light on the ever-changing world of Artificial Intelligence (AI) within the healthcare industry.
As AI technology rapidly advances, the healthcare industry is becoming its most significant and impactful beneficiary. From the authors’ viewpoint, AI is revolutionizing healthcare with the promise of improving patient outcomes, lowering costs, and increasing access and efficiency. The use of AI in healthcare is not a new concept. In fact, it has been around for decades, but it is only in recent years that its potential has been fully realized. From the development of new surgical techniques to the use of telemedicine for remote patient care, technology has revolutionized the way healthcare is delivered. With the rise of big data and cloud computing, AI will be an essential toolkit for healthcare professionals, enabling them to harness the immense data power in ways that were previously unimaginable. With real-world case studies, practical applications, and purpose methods, Strategies for Artificial Intelligence in Healthcare is the ultimate guide to navigating the modern healthcare industry with AI. The second edition provides up-to-date material and refreshes and updates case studies.
Whether you're an experienced healthcare professional wanting to stay up to date or simply curious about the latest technology, this book offers unique and valuable insights for the future of healthcare with Artificial Intelligence by its side.
"Riassunto" può appartenere a un’altra edizione di questo titolo.
Informazioni sull’autore
Dr. Frank A. Papay, MD, MS, DSc(hon), FACS, FAAP, FNAI, is a physician–executive, surgeon–scientist, inventor, and healthcare systems innovator whose career spans more than three decades at Cleveland Clinic (Cleveland, Ohio, USA), one of the world’s leading academic health systems. He currently serves as Chief Clinical Business Development Officer of Cleveland Clinic Enterprise and former Chairman of Dermatology and Plastic Surgery Institute, where he advises enterprise leadership on growth strategy, innovation portfolio governance, translational commercialization, and AI-enabled care delivery across a $16B+ global healthcare organization.
Dr. Papay is internationally recognized for pioneering work at the intersection of advanced surgery, medical technology, and artificial intelligence. As lead surgeon for America’s first total face transplant, he helped establish the clinical, ethical, and regulatory framework for vascularized composite allotransplantation in the United States. His career includes numerous surgical “firsts,” including novel neuromodulation approaches for chronic pain and migraine, robotic endoscopic nerve reconstruction, and minimally invasive skull-base procedures that replaced high-morbidity open operations.
A prolific innovator, Dr. Papay is an inventor on 40+ issued U.S. patents and 70+ provisional patents spanning surgical devices, digital platforms, neuromodulation technologies, and AI-assisted systems. He has founded and advised multiple venture-backed healthcare companies, guiding technologies from concept through first-in-human trials, regulatory pathways, and institutional capital raises. His experience includes collaboration with venture capital, private equity, and sovereign-aligned investment platforms focused on scaling healthcare innovation globally.
A central focus of his recent work is the integration of artificial intelligence into clinical operations, surgical navigation, and healthcare system performance. Dr. Papay is Co-Founder of BrainX.AI, a global consortium developing machine learning systems for healthcare applications, including surgical intelligence, predictive analytics, and AI-driven decision support. His work emphasizes responsible AI adoption, clinical governance, and translating data science into measurable improvements in patient outcomes, operational efficiency, and system scalability.
Dr. Papay has authored or co-authored more than 260 peer-reviewed scientific publications and multiple foundational scholarly texts. His books include Reconstructive Allotransplantation, a landmark reference in composite tissue transplantation; Virtual Surgical Planning in Surgery, advancing digital precision surgery; Voices of Innovation: Essays on Artificial Intelligence in Healthcare; and Artificial Intelligence Strategies in Healthcare, where he contributes leadership perspectives on AI governance, clinical integration, and system transformation.
He is a Fellow of the National Academy of Inventors and recipient of the Cleveland Clinic’s prestigious Sones Centennial Innovation Award, among many national and international honors. Across his clinical, academic, and executive roles, Dr. Papay’s work bridges medicine, engineering, and AI, shaping how intelligent technologies are responsibly deployed to build the next generation of healthcare delivery systems worldwide.
Dr. Piyush Mathur, MD, FCCM, FASA FAMIA, is a Staff Anesthesiologist and Critical Care Physician at Cleveland Clinic, Ohio, USA, with more than 20 years of experience as a clinician. He is the Innovation Lead for the Department of Anesthesiology, Cleveland Clinic.
He has also served in the role of the Quality Improvement Officer and Chair, Compliance Committee, Anesthesiology Institute for more than a decade. He completed his medical school training in India at the Armed Forces Medical College (AFMC, Pune), followed by residency in Anesthesiology and a fellowship in Critical Care at Cleveland Clinic.
He subsequently completed a one-year quality fellowship at Cleveland Clinic. He has completed training in computer programming, machine learning, and deep learning. He is the Past Program Director of the Anesthesiology Critical Care fellowship program at Cleveland Clinic. A recognized leader in critical care, quality, education, and artificial intelligence applications in healthcare, he has led many of the local and national programs, including serving as the chair of the post-graduate education and coding and documentation committees of the Society of Critical Care Medicine (SCCM).
He is currently a member of the CPT Editorial Advisory Committee, AMA (American Medical Association) and a primary advisor to SCCM. Trained in computer programming, machine learning, and deep learning, he is the founder of BrainX, an AI in healthcare application research and development company. He also founded one of the largest groups for machine learning in healthcare, BrainX Community. He has focused his research on applications of artificial intelligence (AI) in healthcare for many years. He is a leader in quality and patient safety who has innovated and successfully implemented many algorithms and tools in electronic health records such as difficult airway identification (EPIC), anesthesia awareness alert (DSS, Talis), and antibiotic alert (ACG, Talis).
Recipient of multiple innovation awards at Cleveland Clinic, he is leading innovation efforts in integrating machine learning and artificial intelligence in healthcare. Current projects include AIDE (Artificial Intelligence Diagnosis Engine), SALUS (robotic artificial intelligence patient safety system), and BRAINS (Biologically Relational Artificial Intelligence Networking System).
He is a recipient of numerous local and international awards including the Institute of Healthcare Improvement (IHI) Permanente Award and the prestigious Presidential Citation from the Society of Critical Care Medicine (SCCM). He has made numerous local, national, and international presentations and publications in the fields of anesthesiology, critical care, quality, education, and artificial intelligence applications in healthcare. For his work in the field of AI and healthcare, he was awarded the AI Clinician of the Year at the 2025 AIMed Conference.
"Descrizione articolo" può appartenere a un’altra edizione di questo titolo.
AHA-BUCH GmbH
Einbeck, Germania
Venditore AbeBooks dal 14 agosto 2006
Tariffe di spedizione da Germania a U.S.A.
| Articolo | Da 7 a 10 giorni lavorativi | Da 5 a 7 giorni lavorativi |
|---|---|---|
| Primo articolo | EUR 35,00 | EUR 45,00 |
Metodi di pagamento
- Assegno
- Bonifico bancario
- PayPal
Descrizione dello Store
Das Unternehmen AHA-BUCH GmbH: Seit der Gründung von AHA-BUCH im Juli 2005 ist unser Hauptziel, zufriedenen Kunden so schnell und so preisgünstig wie möglich ihren Bücherwunsch zu erfüllen. Unsere Firma beschäftigt 16 Mitarbeiter, die nur ein Ziel kennen: den Kunden und seine Wünsche! Auf über 3700 m2 Fläche haben wir über 100.000 Bücher, Modernes Antiquariat und Spiele auf Lager.
Specializzazione
Kinderbücher & Kinderhör Casetten, German Books, Software, Natur & Tiere, Ratgeber, Sachbücher, Englische Bücher, Medizin & Gesundheit, Universität & StudiumInformazioni sull’azienda del venditore
AHA-BUCH GmbH
Garlebsen 48
Einbeck, Germania 37574
Condizioni di vendita
Imprimere
Informazioni sul venditore:
AHA-BUCH GmbH
rappresentata dall'amministratore delegato Christel Glass
Garlebsen 48
37574 Einbeck
Germania
Telefono: 055639996039
Fax: 055639995974
E-Mail: abebooks@aha-buch.de
USt-IdNr.: DE261904229
registrato presso Registro delle imprese Amtsgerichtes Göttingen
Handelsregisternummer HRB 200691
Risoluzione alternativa delle controversie:
La Commissione europea fornisce una piattaforma per la risoluzione extragiudiziale delle controversie online (piattaforma ODR), accessibile nell'ambito di https://ec.europa.eu/odr.
Siamo membri dell'iniziativa "FairCommerce" dal 25.05.2018.
Per ulteriori informazioni, vedere www.fair-commerce.de.
Diritto di recesso
Se sei un consumatore puoi recedere dal contratto in conformità con quanto segue. Per Consumatore si intende qualsiasi persona fisica che agisce per scopi estranei alla propria attività commerciale, imprenditoriale, artigianale o professionale.
Informazioni sul diritto di recesso
Diritto legale di recesso
Hai il diritto di recedere dal presente contratto entro 14 giorni senza fornire alcuna motivazione.
Il periodo di recesso scade dopo 14 giorni dal giorno in cui tu o una terza parte, diversa dal vettore e da te indicata, acquisisce il possesso fisico dell'ultimo bene o dell'ultimo lotto o pezzo.
Per esercitare il diritto di recesso, compila e invia elettronicamente una dichiarazione esplicita sul nostro sito Web, alla voce “I miei acquisti” nella sezione “Mio account”. Ti comunicheremo senza indugio una conferma di ricezione di tale recesso su un supporto durevole (ad es. via e-mail).
Per rispettare il termine di recesso, è sufficiente inviare la comunicazione relativa all'esercizio del diritto di recesso prima della scadenza del periodo di recesso stesso.
Effetti del recesso
In caso di recesso dal presente contratto, ti rimborseremo tutti i pagamenti ricevuti, compresi i costi di spedizione (ad eccezione dei costi supplementari derivanti dalla tua eventuale scelta di un tipo di spedizione diverso dal tipo meno costoso di consegna standard da noi offerto).
Potremo effettuare una detrazione dal rimborso per la perdita di valore dei beni forniti, qualora tale perdita sia il risultato di una manipolazione non necessaria da parte tua.
Eseguiremo il rimborso senza indebito ritardo e non oltre 14 giorni dal giorno in cui saremo informati della tua decisione di recedere dal presente contratto.
Il rimborso sarà effettuato utilizzando lo stesso mezzo di pagamento da te usato per la transazione iniziale, salvo che tu non abbia espressamente concordato altrimenti; in ogni caso, non dovrai sostenere alcun costo quale conseguenza di tale rimborso.
Possiamo trattenere il rimborso finché non avremo ricevuto i beni oppure finché non avrai fornito la prova di averli rispediti, a seconda di quale condizione si verifichi per prima.
Dovrai rispedire i beni o consegnarli a AHA-BUCH GmbH, Einbeck, Germany, senza indebito ritardo e, in ogni caso, entro 14 giorni dal giorno in cui ci hai comunicato la tua volontà di recedere dal presente contratto. Il termine è rispettato se rispedisci i beni prima della scadenza del periodo di 14 giorni. I costi diretti della restituzione dei beni saranno a tuo carico. Sei responsabile solo della diminuzione del valore dei beni risultante da una manipolazione diversa da quella necessaria per stabilire la natura, le caratteristiche e il funzionamento dei beni stessi.
Eccezioni al diritto di recesso
Il diritto di recesso non si applica a:
- La fornitura di giornali, periodici o riviste ad eccezione dei contratti di abbonamento; e
- La fornitura di contenuto digitale non fornito su un supporto materiale (ad es. su un CD o DVD), se al momento dell'invio dell'ordine hai accettato l'inizio dell'esecuzione e hai riconosciuto che non avresti potuto recedere una volta iniziata l'esecuzione.
Condizioni di spedizione
Spediamo il tuo ordine dopo averlo ricevuto
per articoli a portata di mano entro 24 ore,
per articoli con fornitura notturna entro 48 ore.
Nel caso in cui abbiamo bisogno di ordinare un articolo dal nostro fornitore, il nostro tempo di spedizione dipende dalla data di ricezione degli articoli, ma gli articoli verranno spediti lo stesso giorno.
Il nostro obiettivo è quello di inviare gli articoli ordinati nel modo più veloce, ma anche più efficiente e sicuro ai nostri clienti.